Receptor for AGEs (RAGE) blockade may exert its renoprotective effects in patients with diabetic nephropathy via induction of the angiotensin II type 2 (AT2) receptor
AIMS/HYPOTHESIS: The receptor for AGEs (RAGE) contributes to the development and progression of diabetic nephropathy. In this study, we examined whether the protective effects of RAGE blockade are exerted via modulation of the renal angiotensin II type 2 (AT2) receptor. - METHODS: Control and strept...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2010 November
|
| In: |
Diabetologia
Year: 2010, Jahrgang: 53, Heft: 11, Pages: 2442-2451 |
| ISSN: | 1432-0428 |
| Online-Zugang: |
|
| Verfasserangaben: | K.C. Sourris, A.L. Morley, A. Koitka, P. Samuel, M.T. Coughlan, S.A. Penfold, M.C. Thomas, A. Bierhaus, P.P. Nawroth, H. Yamamoto, T.J. Allen, T. Walther, T. Hussain, M.E. Cooper, and J.M. Forbes |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1860627951 | ||
| 003 | DE-627 | ||
| 005 | 20240329080800.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231002s2010 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00125-010-1837-2 |2 doi | |
| 035 | |a (DE-627)1860627951 | ||
| 035 | |a (DE-599)KXP1860627951 | ||
| 035 | |a (OCoLC)1425873647 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Sourris, Karly C. |e VerfasserIn |0 (DE-588)1304723453 |0 (DE-627)1860627129 |4 aut | |
| 245 | 1 | 0 | |a Receptor for AGEs (RAGE) blockade may exert its renoprotective effects in patients with diabetic nephropathy via induction of the angiotensin II type 2 (AT2) receptor |c K.C. Sourris, A.L. Morley, A. Koitka, P. Samuel, M.T. Coughlan, S.A. Penfold, M.C. Thomas, A. Bierhaus, P.P. Nawroth, H. Yamamoto, T.J. Allen, T. Walther, T. Hussain, M.E. Cooper, and J.M. Forbes |
| 264 | 1 | |c 2010 November | |
| 300 | |a 22 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 02.10.2023 | ||
| 520 | |a AIMS/HYPOTHESIS: The receptor for AGEs (RAGE) contributes to the development and progression of diabetic nephropathy. In this study, we examined whether the protective effects of RAGE blockade are exerted via modulation of the renal angiotensin II type 2 (AT2) receptor. - METHODS: Control and streptozotocin diabetic mice, wild-type or deficient in the AT2 receptor (At2 knockout [KO]) or RAGE (Rage KO), were studied for 24 weeks. Adenoviral overexpression of full-length Rage in primary rat mesangial cells was also used to determine the effects on AT2 production. - RESULTS: With diabetes, Rage-deficient mice had less albuminuria, and an attenuation of hyperfiltration and glomerulosclerosis as compared with diabetic wild-type and At2 KO mice. Renal gene and protein expression of RAGE was elevated with diabetes. Diabetic Rage KO mice had a greater increase in renal AT2 receptor protein than was seen in diabetic wild-type mice. Diabetes-induced increases in renal cytosolic and mitochondrial superoxide generation were prevented in diabetic Rage KO mice, but enhanced in all At2 KO mice. Adenoviral overexpression of RAGE or AGE treatment decreased cell surface AT2 expression, in association with increasing superoxide generation; both were reversed using antioxidants N-acetylcysteine and apocynin, and soluble RAGE in primary mesangial cells. - CONCLUSIONS/INTERPRETATION: RAGE appears to be a common and key modulator of AT2 receptor expression, a finding that would implicate a newly defined RAGE-AT2 axis in the development and progression of diabetic nephropathy. | ||
| 650 | 4 | |a Animals | |
| 650 | 4 | |a Diabetic Nephropathies | |
| 650 | 4 | |a Female | |
| 650 | 4 | |a Humans | |
| 650 | 4 | |a Kidney | |
| 650 | 4 | |a Kidney Function Tests | |
| 650 | 4 | |a Male | |
| 650 | 4 | |a Mice | |
| 650 | 4 | |a Mice, Knockout | |
| 650 | 4 | |a Random Allocation | |
| 650 | 4 | |a Rats | |
| 650 | 4 | |a Receptor for Advanced Glycation End Products | |
| 650 | 4 | |a Receptor, Angiotensin, Type 2 | |
| 650 | 4 | |a Receptors, Immunologic | |
| 650 | 4 | |a Superoxides | |
| 700 | 1 | |a Morley, A. L. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Koitka, A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Samuel, P. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Coughlan, M. T. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Penfold, S. A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Thomas, M. C. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bierhaus, Angelika |d 1962-2012 |e VerfasserIn |0 (DE-588)1038392292 |0 (DE-627)757235271 |0 (DE-576)175591814 |4 aut | |
| 700 | 1 | |a Nawroth, Peter Paul |d 1954- |e VerfasserIn |0 (DE-588)1020504897 |0 (DE-627)69123941X |0 (DE-576)360517692 |4 aut | |
| 700 | 1 | |a Yamamoto, H. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Allen, T. J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Walther, T. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hussain, T. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Cooper, M. E. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Forbes, J. M. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Diabetologia |d Berlin : Springer, 1965 |g 53(2010), 11, Seite 2442-2451 |h Online-Ressource |w (DE-627)253722209 |w (DE-600)1458993-X |w (DE-576)072372354 |x 1432-0428 |7 nnas |a Receptor for AGEs (RAGE) blockade may exert its renoprotective effects in patients with diabetic nephropathy via induction of the angiotensin II type 2 (AT2) receptor |
| 773 | 1 | 8 | |g volume:53 |g year:2010 |g number:11 |g pages:2442-2451 |g extent:22 |a Receptor for AGEs (RAGE) blockade may exert its renoprotective effects in patients with diabetic nephropathy via induction of the angiotensin II type 2 (AT2) receptor |
| 951 | |a AR | ||
| 992 | |a 20231002 | ||
| 993 | |a Article | ||
| 994 | |a 2010 | ||
| 998 | |g 1020504897 |a Nawroth, Peter Paul |m 1020504897:Nawroth, Peter Paul |d 910000 |d 910100 |e 910000PN1020504897 |e 910100PN1020504897 |k 0/910000/ |k 1/910000/910100/ |p 8 | ||
| 998 | |g 1038392292 |a Bierhaus, Angelika |m 1038392292:Bierhaus, Angelika |d 910000 |d 910100 |e 910000PB1038392292 |e 910100PB1038392292 |k 0/910000/ |k 1/910000/910100/ |p 7 | ||
| 999 | |a KXP-PPN1860627951 |e 4380592006 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["K.C. Sourris, A.L. Morley, A. Koitka, P. Samuel, M.T. Coughlan, S.A. Penfold, M.C. Thomas, A. Bierhaus, P.P. Nawroth, H. Yamamoto, T.J. Allen, T. Walther, T. Hussain, M.E. Cooper, and J.M. Forbes"]},"id":{"doi":["10.1007/s00125-010-1837-2"],"eki":["1860627951"]},"origin":[{"dateIssuedDisp":"2010 November","dateIssuedKey":"2010"}],"physDesc":[{"extent":"22 S."}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"Berlin ; Heidelberg","dateIssuedKey":"1965","dateIssuedDisp":"1965-","publisher":"Springer"}],"disp":"Receptor for AGEs (RAGE) blockade may exert its renoprotective effects in patients with diabetic nephropathy via induction of the angiotensin II type 2 (AT2) receptorDiabetologia","language":["eng"],"title":[{"title_sort":"Diabetologia","title":"Diabetologia","subtitle":"journal of the European Association for the Study of Diabetes (EASD)"}],"pubHistory":["1.1965/66 -"],"type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 27. November 2017","Ungezählte Beil.: Supplement"],"recId":"253722209","part":{"text":"53(2010), 11, Seite 2442-2451","pages":"2442-2451","year":"2010","extent":"22","volume":"53","issue":"11"},"id":{"issn":["1432-0428"],"zdb":["1458993-X"],"eki":["253722209"]},"corporate":[{"role":"isb","roleDisplay":"Herausgebendes Organ","display":"European Association for the Study of Diabetes"}]}],"person":[{"roleDisplay":"VerfasserIn","role":"aut","given":"Karly C.","display":"Sourris, Karly C.","family":"Sourris"},{"display":"Morley, A. L.","given":"A. L.","roleDisplay":"VerfasserIn","role":"aut","family":"Morley"},{"display":"Koitka, A.","given":"A.","role":"aut","roleDisplay":"VerfasserIn","family":"Koitka"},{"display":"Samuel, P.","role":"aut","roleDisplay":"VerfasserIn","given":"P.","family":"Samuel"},{"roleDisplay":"VerfasserIn","role":"aut","given":"M. T.","display":"Coughlan, M. T.","family":"Coughlan"},{"family":"Penfold","roleDisplay":"VerfasserIn","role":"aut","given":"S. A.","display":"Penfold, S. A."},{"family":"Thomas","role":"aut","roleDisplay":"VerfasserIn","given":"M. C.","display":"Thomas, M. C."},{"family":"Bierhaus","roleDisplay":"VerfasserIn","role":"aut","given":"Angelika","display":"Bierhaus, Angelika"},{"family":"Nawroth","display":"Nawroth, Peter Paul","given":"Peter Paul","roleDisplay":"VerfasserIn","role":"aut"},{"display":"Yamamoto, H.","roleDisplay":"VerfasserIn","role":"aut","given":"H.","family":"Yamamoto"},{"role":"aut","roleDisplay":"VerfasserIn","given":"T. J.","display":"Allen, T. J.","family":"Allen"},{"family":"Walther","roleDisplay":"VerfasserIn","role":"aut","given":"T.","display":"Walther, T."},{"family":"Hussain","display":"Hussain, T.","role":"aut","roleDisplay":"VerfasserIn","given":"T."},{"family":"Cooper","given":"M. E.","role":"aut","roleDisplay":"VerfasserIn","display":"Cooper, M. E."},{"family":"Forbes","display":"Forbes, J. M.","role":"aut","roleDisplay":"VerfasserIn","given":"J. M."}],"language":["eng"],"title":[{"title_sort":"Receptor for AGEs (RAGE) blockade may exert its renoprotective effects in patients with diabetic nephropathy via induction of the angiotensin II type 2 (AT2) receptor","title":"Receptor for AGEs (RAGE) blockade may exert its renoprotective effects in patients with diabetic nephropathy via induction of the angiotensin II type 2 (AT2) receptor"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 02.10.2023"],"recId":"1860627951"} | ||
| SRT | |a SOURRISKARRECEPTORFO2010 | ||